Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Response”

6,030 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,030 results

Not applicableUnknownNCT06015061
What this trial is testing

Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients

Who this might be right for
Pheochromocytoma, MetastaticUltrasonographyParaganglioma, Malignant+1 more
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)WithdrawnNCT00257361
What this trial is testing

D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder

Who this might be right for
Obsessive Compulsive Disorder
University of Florida
Not applicableStudy completedNCT02202941
What this trial is testing

Procalcitonin-guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients

Who this might be right for
Sepsis
Seoul National University Hospital 62
Not applicableWithdrawnNCT00517231
What this trial is testing

Cytokines and Acute Phase Reactants as Markers of Pulmonary Tuberculosis Treatment

Who this might be right for
Pulmonary Tuberculosis
UPECLIN HC FM Botucatu Unesp
Not applicableStudy completedNCT03275337
What this trial is testing

Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy

Who this might be right for
Anxiety DisordersSocial Phobia
Laureate Institute for Brain Research, Inc. 60
Testing effectiveness (Phase 2)UnknownNCT04646837
What this trial is testing

Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models

Who this might be right for
Non-small Cell Lung Cancer
Peking Union Medical College Hospital 20
Large-scale testing (Phase 3)Study completedNCT00001937
What this trial is testing

Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients

Who this might be right for
AspergillosisCandidiasisFungemia+1 more
National Cancer Institute (NCI) 800
Very early researchStudy completedNCT07302945
What this trial is testing

A Single-volunteer Study of Immune Response Following OTS-412 Vaccinia Virus Systemic Injection(Self-experiment)

Who this might be right for
Healthy Volunteer
Bionoxx Inc. 1
Large-scale testing (Phase 3)Looking for participantsNCT06079879
What this trial is testing

Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

Who this might be right for
Essential Thrombocythemia
Merck Sharp & Dohme LLC 340
Not applicableLooking for participantsNCT06635954
What this trial is testing

A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.

Who this might be right for
CancerImmunotherapyPD-1+2 more
Oxford Biodynamics Inc. 2,000
Post-approval studies (Phase 4)UnknownNCT05294887
What this trial is testing

Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease

Who this might be right for
Coronary Microvascular DysfunctionMicrovascular AnginaVasospasm, Coronary+3 more
Charite University, Berlin, Germany 132
Not applicableStudy completedNCT06466447
What this trial is testing

Child and Adolescent OCD Outcomes From Exposure and Response Prevention Video Teletherapy Treatment

Who this might be right for
Obsessive-Compulsive Disorder
NOCD 2,173
Not applicableUnknownNCT05051423
What this trial is testing

"Mechanisms and Biomarkers of Response and Resistance to Current Targeted Therapies in Gastric Cancer" (THERRES)

Who this might be right for
Gastric Cancer
University of Medicine and Pharmacy Craiova 40
Not applicableEnded earlyNCT05069259
What this trial is testing

Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.

Who this might be right for
Ulcerative Colitis
Pfizer 18
Not applicableUnknownNCT03958851
What this trial is testing

Renal Resistive Index as a Marker of Severity and Treatment Outcomes in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Assiut University 120
Early research (Phase 1)Study completedNCT02470637
What this trial is testing

Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Mannkind Corporation 30
Not applicableStudy completedNCT04577482
What this trial is testing

Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological Response

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 42
Not applicableStudy completedNCT04896424
What this trial is testing

Vagal Response and Cardiac Autonomic Modulation. Insides From Cryoballoon Ablation

Who this might be right for
Vagal Nerve StimulationAutonomic Nervous SystemCatheter Ablation
Pomeranian Medical University Szczecin 296
Not applicableUnknownNCT05960162
What this trial is testing

Role of 90K/Mac-2 BP as an Indicator of Early Response to Infliximab Therapy in IBD Patients

Who this might be right for
IBD
Assiut University 50
Not applicableStudy completedNCT00085280
What this trial is testing

Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 129
Load More Results